PSA密度不能提高双参数前列腺MR在活检初治患者中对前列腺癌的检出
回顾性分析114例活检初治、MR后30天内行经直肠超声引导活检的患者,比较双参数前列腺MR、PSA密度及其联合的诊断效能。在所有评估场景中,双参数MR的AUC为0.87-0.95,显著高于PSA密度的0.73-0.79,而两者联合的AUC为0.91-0.95,较双参数MR单独无统计学显著改善。
要点
- 活检初治患者中,双参数前列腺MR检出前列腺癌的AUC为0.87-0.95,显著高于PSA密度的0.73-0.79。
- 双参数MR联合PSA密度的AUC为0.91-0.95,较双参数MR单独无统计学显著改善。
- 双参数MR是检出临床显著前列腺癌的有力工具。
核心结论
- 双参数前列腺MR是检出临床显著前列腺癌的有力工具;与近期文献相反,PSA密度似乎不能显著提高其诊断效能。
研究设计与样本
- 回顾性分析334例连续患者,最终纳入114例活检初治、MR后30天内行经直肠超声引导活检的患者,使用3T扫描仪,protocol包括T2加权和DWI序列,以ISUP评分为参考标准。
诊断标准与关键数值
- 采用基于PI-RADS v2的Likert评分评估双参数MR;评估三种场景:ISUP≥1、ISUP≥2和ISUP≥3;双参数MR的AUC为0.87-0.95,PSA密度的AUC为0.73-0.79,联合的AUC为0.91-0.95。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Bi-parametric prostate MR (bp-MR) is a valuable tool for detection and characterization of prostate cancer (PCa). Recent studies suggested that PSA-density (PSA-D) in combination with multi-parametric prostate MR as well as bp-MR may achieve a higher diagnostic accuracy than either alone. We aimed to evaluate the diagnostic performance of bp-MR, PSA-D and their combination in biopsy-naïve patients.
METHODS AND MATERIALS: We retrospectively analyzed 334 consecutive patients who underwent prostate MR on a 3T scanner. Only patients (n = 114) who underwent TRUS-biopsy within 30 days following MR with no previous prostate biopsies were considered. Our protocol included T2-weighted and DWI sequences. A Likert score based on PI-RADS v2 was used for bp-MR evaluation. Lesions were graded histopathologically using the ISUP score. We assessed three scenarios: detection of lesions independently of ISUP score (ISUP ≥ 1), detection of both intermediate and clinically significant lesions (ISUP ≥ 2) and detection of clinically significant lesions alone (ISUP ≥ 3). Predictive value of bp-MR and PSA-D was evaluated by ROC curves and logistic regression analysis. A p value < 0.05 was considered statistically significant.
RESULTS: In all evaluated scenarios, bp-MR showed a significantly higher predictive power (AUC = 0.87-0.95) compared to the performance of PSA-D (AUC = 0.73-0.79), while their combination (AUC = 0.91-0.95) showed no statistically significant improvement compared to bp-MR alone.
CONCLUSION: Our results confirm that bp-MR is a powerful tool in detection of clinically significant PCa. Contrary to findings in the recent literature, PSA-D does not appear to significantly improve its diagnostic performance.
引用
- Cuocolo R, Stanzione A, Rusconi G, et al. PSA-density does not improve bi-parametric prostate MR detection of prostate cancer in a biopsy naïve patient population. Eur J Radiol. 2018. PMID: 29857868. doi:10.1016/j.ejrad.2018.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。